Mirum Pharmaceuticals, Inc. - common stock (MIRM): Price and Financial Metrics
MIRM Price/Volume Stats
| Current price | $23.81 | 52-week high | $35.56 |
| Prev. close | $23.57 | 52-week low | $23.29 |
| Day low | $23.40 | Volume | 336,900 |
| Day high | $24.00 | Avg. volume | 567,089 |
| 50-day MA | $26.90 | Dividend yield | N/A |
| 200-day MA | $28.16 | Market Cap | 1.12B |
MIRM Stock Price Chart Interactive Chart >
Mirum Pharmaceuticals, Inc. - common stock (MIRM) Company Bio
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.
Latest MIRM News From Around the Web
Below are the latest news stories about MIRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate MIRM as an investment opportunity.
Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b Study for Biliary AtresiaFOSTER CITY, Calif., December 18, 2023--Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b Study for Biliary Atresia |
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)FOSTER CITY, Calif., December 09, 2023--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus ManagementDallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to announce the publication of its latest report, titled "Transformative Therapies for Pruritus Management." This comprehensive report delves into the critical issue of pruritus, or chronic itch, and its impact on patients, particularly those suffering from Primary Biliary Cholangitis (PBC), an autoimmune liver disease. ... |
Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx ConferenceFOSTER CITY, Calif., November 20, 2023--Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx Conference |
Mirum Pharmaceuticals Presents New Data at The Liver Meeting®FOSTER CITY, Calif., November 13, 2023--Mirum Pharmaceuticals Presents New Data at The Liver Meeting® |
MIRM Price Returns
| 1-mo | -11.78% |
| 3-mo | -9.57% |
| 6-mo | -17.61% |
| 1-year | -7.57% |
| 3-year | 33.31% |
| 5-year | N/A |
| YTD | -19.34% |
| 2023 | 51.38% |
| 2022 | 22.26% |
| 2021 | -8.65% |
| 2020 | -28.79% |
| 2019 | N/A |
Loading social stream, please wait...